These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16386655)

  • 41. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
    Wentzensen N; Rodriguez AC; Viscidi R; Herrero R; Hildesheim A; Ghosh A; Morales J; Wacholder S; Guillen D; Alfaro M; Safaeian M; Burk RD; Schiffman M
    J Infect Dis; 2011 Jul; 204(1):94-102. PubMed ID: 21628663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.
    Dias D; Van Doren J; Schlottmann S; Kelly S; Puchalski D; Ruiz W; Boerckel P; Kessler J; Antonello JM; Green T; Brown M; Smith J; Chirmule N; Barr E; Jansen KU; Esser MT
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):959-69. PubMed ID: 16085914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epidemiological aspects of cervical neoplasms].
    Aleixo Neto A
    Rev Saude Publica; 1991 Aug; 25(4):326-33. PubMed ID: 1668183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL.
    Sudenga SL; Torres BN; Botha MH; Zeier M; Abrahamsen ME; Glashoff RH; Engelbrecht S; Schim Van der Loeff MF; Van der Laan LE; Kipping S; Taylor D; Giuliano AR
    Papillomavirus Res; 2017 Jun; 3():50-56. PubMed ID: 28480334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of human Papillomavirus 18 in cervical cancer samples using PCR-ELISA (DIAPOPS).
    Raji N; Sadeghizadeh M; Tafreshi KN; Jahanzad E
    Iran J Microbiol; 2011 Dec; 3(4):177-82. PubMed ID: 22530085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-based prevalence versus hospital-based incidence of genital Human Papillomavirus infection in Central Vietnam.
    Nguyen VQH; Ngo VQT; Le MT; Nguyen HB; Phan VBT; Truong QV; Cao NT; Cappuccinelli P
    J Infect Dev Ctries; 2018 Jul; 12(7):568-572. PubMed ID: 31954006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Risk factors of cervical cancer among women in Mozambique].
    Rostad B; Schei B; da Costa F; Onsrud M
    Tidsskr Nor Laegeforen; 2004 May; 124(10):1410-2. PubMed ID: 15195185
    [No Abstract]   [Full Text] [Related]  

  • 48. Sexual activity and cervical cancer: the pap test quest.
    Rodney MB
    Bedside Nurse; 1971 Apr; 4(4):14-6. PubMed ID: 5205721
    [No Abstract]   [Full Text] [Related]  

  • 49. 25-hydroxycholesterol inhibits human papillomavirus infection in cervical epithelial cells by perturbing cytoskeletal remodeling.
    Li B; Hua C; Tian P; Sha Y; Zhang L; Wang Q; Lu L; Jiang S; Sui L
    J Med Virol; 2023 Jun; 95(6):e28834. PubMed ID: 37254637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sexual activity and cervical carcinoma.
    Buchsbaum HJ
    J Iowa Med Soc; 1971 Sep; 61(9):559. PubMed ID: 4327842
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.
    Colpani V; Soares Falcetta F; Bacelo Bidinotto A; Kops NL; Falavigna M; Serpa Hammes L; Schwartz Benzaken A; Kalume Maranhão AG; Domingues CMAS; Wendland EM
    PLoS One; 2020; 15(2):e0229154. PubMed ID: 32084177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus detection in cervical scrapes from women attended in the Family Health Program.
    Augusto EF; Santos LS; Oliveira Ldo H
    Rev Lat Am Enfermagem; 2014; 22(1):100-7. PubMed ID: 24553709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus infection in women attended at a cervical cancer screening service in Natal, Brazil.
    de Medeiros Fernandes TA; de Vasconcellos Meissner R; Bezerra LF; de Azevedo PR; Fernandes JV
    Braz J Microbiol; 2008 Jul; 39(3):573-8. PubMed ID: 24031268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of seropositivity among HPV-16/18 DNA positive young women.
    Porras C; Bennett C; Safaeian M; Coseo S; Rodríguez AC; González P; Hutchinson M; Jiménez S; Sherman ME; Wacholder S; Solomon D; van Doorn LJ; Bougelet C; Quint W; Schiffman M; Herrero R; Hildesheim A;
    BMC Infect Dis; 2010 Aug; 10():238. PubMed ID: 20698998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
    Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
    Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil.
    Naud P; Matos J; Hammes L; Stuckzynski J; Brouwers K; Magno V; Dias E; Crusius P; d'Avila A; Campos C; Costa M; Höblik M; Marc C; Marroni R; Syrjänen K
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):110-8. PubMed ID: 16386655
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.